Spinal cord injury often triggers a cascade of secondary damage that severely limits functional recovery, largely driven by ...
Namodenoson (CF102), an investigational small-molecule A3 adenosine receptor (A3AR) agonist, has demonstrated favorable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results